Trial intelligence / Profile preview

Tolerance of virucidal alcohol-based hand rubs in healthy volunteers

2010-018624-20Phase 4Completed

Sponsor
University Hospital Freiburg
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of Softa-Man, Sterillium Virugard and Manorapid Synergy (4 arms), sponsored by University Hospital Freiburg. Primary endpoint: Transepidermal water loss. Started Apr 2010; status: completed.

02

Drugs

Softa-ManSterillium VirugardManorapid Synergy

Beyond the preview

Go deeper on 2010-018624-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-018624-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call